Enliven Therapeutics, Inc. (ELVN)

Last Three Months

16-Feb-24 -- 15-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

29

0

0

+1

0

+2

0

+3

Two Year Chart

16-May-22 -- 15-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
29-Apr-24 6:50 PM View:	25-Apr-24 Planned Option Sale ($202.70K)	Kintz Samuel President and CEO Director		Enliven Therapeutics, Inc. - ELVN	0% 1.26M	0	0	--	--	Show Txns Hide Txns

07-May-24 6:58 PM View:	03-May-24 Planned Option Sale ($22.50K)	Hohl Benjamin Chief Financial Officer		Enliven Therapeutics, Inc. - ELVN	0% --	0	0	--	--	Show Txns Hide Txns

01-May-24 7:04 PM View:	29-Apr-24 Planned Option Sale ($214.99K)	Lyssikatos Joseph P Chief Scientific Officer Director		Enliven Therapeutics, Inc. - ELVN	0% 1.12M	0	0	--	--	Show Txns Hide Txns

13-May-24 7:35 PM View:	09-May-24 Planned Option Sale ($6.52K)	Patel Anish Chief Operating Officer		Enliven Therapeutics, Inc. - ELVN	(3%) 406.37K to 394.03K	0	0	--	--	Show Txns Hide Txns

15-Apr-24 7:03 PM View:	15-Apr-24 Sale (Planned) ($25.38K)	Heyman Richard A. Director		Enliven Therapeutics, Inc. - ELVN	(4%) 211.36K to 203.13K	0	0	--	--	Show Txns Hide Txns

12-Apr-24 6:23 PM View:	11-Apr-24 Planned Option Sale ($1.28M)	Ballal Rahul D. Director		Enliven Therapeutics, Inc. - ELVN	0% 22.34K	0	0	--	--	Show Txns Hide Txns

15-Apr-24 7:02 PM View:	11-Apr-24 Planned Option Sale ($501.48K)	Collins Helen Louise Chief Medical Officer		Enliven Therapeutics, Inc. - ELVN	0% --	0	0	--	--	Show Txns Hide Txns